摘要
小胶质细胞和星形胶质细胞在神经发展及维持健康大脑突触连接和体内平衡的意义已经确立。小胶质细胞是大脑损伤时引起免疫反应的动态免疫细胞,也参与组织修复和再生,而星形胶质细胞通过产生促炎细胞因子产生局部炎症通过抗炎细胞因子和神经营养因子的生产解决神经损伤,。最近的努力致力于阐明在正常和病理状态下调节神经胶质细胞的表观遗传机制。表观遗传监管机制的一个重要的分子是小分子核糖核苷酸,它是调节转录后基因表达的小非编码RNA分子,。某些特异表达有助于慢性小胶质脑部炎症,从而促进神经系统疾病研究进展如阿尔茨海默氏症、创伤性损伤,肌萎缩性脊髓侧索硬化症和中风。此外,缺血和脊椎损伤后,许多小分子核糖核苷酸在星形胶质细胞差异表达。尽管在神经炎症的小分子核糖核苷酸知识体系中,很少是关于小分子核糖核苷酸为基础疗法有效的配送路线和药代动力学数据。综述总结了小分子核糖核苷酸在小胶质细胞和星形胶质细胞以特定疾病的方式促进或抑制炎症反应的研究。此外,针对以小分子核糖核苷酸传送作为治疗神经炎症治疗策略进行了探讨。
关键词: 神经炎症、小胶质细胞、星形胶质细胞、小分子核糖核酸
Current Medicinal Chemistry
Title:MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Volume: 23 Issue: 30
Author(s): Aparna Karthikeyan, Radhika Patnala, Shweta P. Jadhav, Ling Eng-Ang, S. Thameem Dheen
Affiliation:
关键词: 神经炎症、小胶质细胞、星形胶质细胞、小分子核糖核酸
摘要: The significance of microglia and astrocytes in neural development, in maintaining synaptic connections and homeostasis in the healthy brain is well established. Microglia are dynamic immune cells of the brain that elicit an immune response during brain damage and also participate in tissue repair and regeneration, while astrocytes contribute to the local inflammatory response by producing proinflammatory cytokines and resolving neuronal damage through production of anti-inflammatory cytokines and neurotrophic factors. Recent efforts have focused on elucidating the epigenetic mechanisms which regulate glial cell behavior in normal and pathologic states. An important class of epigenetic regulators is microRNAs (miRNAs) which are small non-coding RNA molecules that regulate gene expression posttranscriptionally. Certain dysregulated miRNAs contribute to chronic microglial inflammation in the brain, thereby leading to progression of neurological diseases like Alzheimer’s disease, traumatic injury, amyotrophic lateral sclerosis and stroke. Further, several miRNAs are differentially expressed in astrocytes after ischemia and spinal cord injury. Despite knowledge about miRNAs in neuroinflammation, little is known about effective delivery routes and pharmacokinetic data for miRNA based therapeutics. This review summarizes the current research on the role of miRNAs in promoting and inhibiting inflammatory response of microglia and astrocytes in a disease-specific manner. In addition, miRNA delivery as a therapeutic strategy to treat neuroinflammation is discussed.
Export Options
About this article
Cite this article as:
Aparna Karthikeyan, Radhika Patnala, Shweta P. Jadhav, Ling Eng-Ang, S. Thameem Dheen , MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies, Current Medicinal Chemistry 2016; 23 (30) . https://dx.doi.org/10.2174/0929867323666160814001040
DOI https://dx.doi.org/10.2174/0929867323666160814001040 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interstitial Lung Disease Associated with Collagen Vascular Disease
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Marine Collagen as a Source of Bioactive Molecules: A Review
The Natural Products Journal Molecular Players at the Intersection of Obesity and Osteoarthritis
Current Drug Targets Phospholipase D Inhibition: Beneficial and Harmful Consequences for a Double-Dealer Enzyme
Current Enzyme Inhibition New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Current Drug Targets Cardiac Role of the Transcription Factor NF-κB
Cardiovascular & Hematological Disorders-Drug Targets The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets An Efficient Machine Learning Model for Prediction of Acute Myocardial Infarction
Recent Advances in Computer Science and Communications Patent Selections
Recent Patents on Cardiovascular Drug Discovery Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design A Review of the Characteristics, Properties and Methods for Quantification of Roxithromycin
Current Pharmaceutical Analysis Massively Parallel Screening of the Receptorome
Combinatorial Chemistry & High Throughput Screening Epidemiology of Vitamin D and Colorectal Cancer
Anti-Cancer Agents in Medicinal Chemistry The Role of Natural Killer T Cells in Atherosclerosis
Current Immunology Reviews (Discontinued)